%0 Journal Article
%T Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)
%A Egon Stenager
%A Elena Didenko Pedersen
%A G Magnussen
%A JL Vadgaard
%A Jette L Frederiksen
%A MB Jensen
%A N Meland
%A R Schmid
%J Archive of "Patient preference and adherence".
%D 2018
%R 10.2147/PPA.S154417
%X Disease modifying drugs help control the course of relapsing remitting multiple sclerosis (RRMS); however, good adherence is needed for long-term outcomes
%K adherence
%K multiple sclerosis
%K relapsing remitting MS
%K subcutaneous interferon beta-1a
%K RebiSmart
%K trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916453/